Literature DB >> 7542079

The significance of isoallergenic variations in present and future specific immunotherapy.

H Løwenstein1, S H Sparholt, S S Klysner, H Ipsen, J N Larsen.   

Abstract

The isoallergenic variation of the tree pollen major allergens has been studied by 2D gel electrophoresis, and by analysis of several recombinant clones. The studies have included both antibody-based and T cell stimulation assays. Bet v 1, the major allergen of birch, forms at least 24 spots when conventional extracts are analyzed by 2D gel electrophoresis. Comparison of Bet v 1-encoding DNA sequences reveals a considerable number of amino acid substitutions. This sequence variation can theoretically account for the number of spots observed in 2D gels. Whereas pools of serum from allergic individuals and monospecific antibodies raised in rabbits bind to most if not all spots in 2D gels, analyses of individual serum and/or murine monoclonal antibodies show individual patterns of reactivity with various subsets of spots. These observations point to a model in which amino acid substitutions induce local perturbations of the allergen surface, causing differences in epitope structure. Furthermore, analysis of pollen from individual trees shows that each tree produces individual subsets of Bet v 1 spots. When analyzed in stimulation assays, T cell clones also display differences in reactivity to different isoallergens. In conclusion, we have shown that Bet v 1 is heterogeneous, and that individual trees produce various subsets of isoallergens which display differences in reactivity both towards antibodies and T cells. A careful selection of isoform may therefore be of major importance if recombinant allergens or synthetic peptides are to be used for conventional immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542079     DOI: 10.1159/000237004

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

Review 1.  Recombinant allergens.

Authors:  C Grégoire; M D Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Molecular characterization of allergens.

Authors:  S S Mohapatra; R F Lockey
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 3.  Recombinant allergens/allergen standardization.

Authors:  H Løwenstein; J N Larsen
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 4.  A genetic engineering strategy to eliminate peanut allergy.

Authors:  Hortense Dodo; Koffi Konan; Olga Viquez
Journal:  Curr Allergy Asthma Rep       Date:  2005-01       Impact factor: 4.919

Review 5.  Optimization of allergen standardization.

Authors:  Kyoung Yong Jeong; Chein-Soo Hong; Joo-Shil Lee; Jung-Won Park
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.